North America Travel Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The North America travel vaccines market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.
Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They generally consist of an agent made from the surface protein, toxins, weakened or killed forms of the disease-causing microorganisms. Vaccination enables the body to produce antibodies, which provide a shield in case the person is exposed to the disease. For travel vaccines, also known as travel immunizations, travelers are vaccinated 4 to 6 weeks before the journey. These can be differentiated between recommended and required vaccines. Wherein, required vaccines are essential for the individual to get before entering a country. However, recommended vaccines are those which the traveler may need because of a potential infection threat in the country or a part of that country. Some of the most common vaccine-preventable, travel-related diseases include influenza, meningitis, rabies, tick-borne encephalitis, polio, diphtheria, tetanus, pertussis, etc.
North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease. As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America travel vaccines market report, along with forecasts at the regional and country levels from 2023-2028. Our report has categorized the market based on composition and disease.
Key Regions Analysed
United States
Canada
Mexico
Analysis for Each Country
Market by Composition
Mono Vaccines
Combination Vaccines
Market by Disease
Hepatitis A
DPT
Yellow Fever
Typhoid
Hepatitis B
Measles and Mumps
Rabies
Meningococcal
Varicella
Japanese Encephalitis
Others
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
PESTEL Analysis
Government Regulations
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report
1. What was the size of the North America travel vaccines market in 2022?
2. What is the expected growth rate of the North America travel vaccines market during 2023-2028?
3. What are the key factors driving the North America travel vaccines market?
4. What has been the impact of COVID-19 on the North America travel vaccines market?
5. What is the breakup of the North America travel vaccines market based on the composition?
6. What is the breakup of the North America travel vaccines market based on the disease?
7. What are the key regions in the North America travel vaccines market?
The North America travel vaccines market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.
Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They generally consist of an agent made from the surface protein, toxins, weakened or killed forms of the disease-causing microorganisms. Vaccination enables the body to produce antibodies, which provide a shield in case the person is exposed to the disease. For travel vaccines, also known as travel immunizations, travelers are vaccinated 4 to 6 weeks before the journey. These can be differentiated between recommended and required vaccines. Wherein, required vaccines are essential for the individual to get before entering a country. However, recommended vaccines are those which the traveler may need because of a potential infection threat in the country or a part of that country. Some of the most common vaccine-preventable, travel-related diseases include influenza, meningitis, rabies, tick-borne encephalitis, polio, diphtheria, tetanus, pertussis, etc.
North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease. As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America travel vaccines market report, along with forecasts at the regional and country levels from 2023-2028. Our report has categorized the market based on composition and disease.
Key Regions Analysed
United States
Canada
Mexico
Analysis for Each Country
Market by Composition
Mono Vaccines
Combination Vaccines
Market by Disease
Hepatitis A
DPT
Yellow Fever
Typhoid
Hepatitis B
Measles and Mumps
Rabies
Meningococcal
Varicella
Japanese Encephalitis
Others
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
PESTEL Analysis
Government Regulations
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report
1. What was the size of the North America travel vaccines market in 2022?
2. What is the expected growth rate of the North America travel vaccines market during 2023-2028?
3. What are the key factors driving the North America travel vaccines market?
4. What has been the impact of COVID-19 on the North America travel vaccines market?
5. What is the breakup of the North America travel vaccines market based on the composition?
6. What is the breakup of the North America travel vaccines market based on the disease?
7. What are the key regions in the North America travel vaccines market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL TRAVEL VACCINES MARKET
5.1Market Performance
5.2Market Breakup by Composition
5.3Market Breakup by Disease
5.4Market Breakup by Region
5.5Market Forecast
6 NORTH AMERICA TRAVEL VACCINES MARKET
6.1Market Performance
6.2Impact of COVID-19
6.3Market Forecast
7 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY COMPOSITION
7.1Mono Vaccines
7.2Combination Vaccines
8 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY DISEASE
8.1Hepatitis A
8.2DPT
8.3Yellow Fever
8.4Typhoid
8.5Hepatitis B
8.6Measles and Mumps
8.7Rabies
8.8Meningococcal
8.9Varicella
8.10Japanese Encephalitis
8.11Others
9 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY COUNTRY
9.1 United States
9.1.1Historical Market Trends
9.1.2Market Breakup by Composition
9.1.3Market Breakup by Disease
9.1.4Market Forecast
9.2 Canada
9.2.1Historical Market Trends
9.2.2Market Breakup by Composition
9.2.3Market Breakup by Disease
9.2.4Market Forecast
9.3 Mexico
9.3.1Historical Market Trends
9.3.2Market Breakup by Composition
9.3.3Market Breakup by Disease
9.3.4Market Forecast
10 SWOT ANALYSIS
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11 VALUE CHAIN ANALYSIS
11.1 Overview
11.2 Exploratory Stage
11.3 Preclinical and Clinical Development
11.4 Regulatory Approval
11.5 Manufacturing
11.6 Marketing and Distribution
12 PORTER’S FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Rivalry
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL TRAVEL VACCINES MARKET
5.1Market Performance
5.2Market Breakup by Composition
5.3Market Breakup by Disease
5.4Market Breakup by Region
5.5Market Forecast
6 NORTH AMERICA TRAVEL VACCINES MARKET
6.1Market Performance
6.2Impact of COVID-19
6.3Market Forecast
7 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY COMPOSITION
7.1Mono Vaccines
7.2Combination Vaccines
8 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY DISEASE
8.1Hepatitis A
8.2DPT
8.3Yellow Fever
8.4Typhoid
8.5Hepatitis B
8.6Measles and Mumps
8.7Rabies
8.8Meningococcal
8.9Varicella
8.10Japanese Encephalitis
8.11Others
9 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY COUNTRY
9.1 United States
9.1.1Historical Market Trends
9.1.2Market Breakup by Composition
9.1.3Market Breakup by Disease
9.1.4Market Forecast
9.2 Canada
9.2.1Historical Market Trends
9.2.2Market Breakup by Composition
9.2.3Market Breakup by Disease
9.2.4Market Forecast
9.3 Mexico
9.3.1Historical Market Trends
9.3.2Market Breakup by Composition
9.3.3Market Breakup by Disease
9.3.4Market Forecast
10 SWOT ANALYSIS
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11 VALUE CHAIN ANALYSIS
11.1 Overview
11.2 Exploratory Stage
11.3 Preclinical and Clinical Development
11.4 Regulatory Approval
11.5 Manufacturing
11.6 Marketing and Distribution
12 PORTER’S FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Rivalry
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
LIST OF TABLES
Table 1: North America: Travel Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: North America: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2023-2028
Table 3: North America: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2023-2028
Table 4: North America: Travel Vaccines Market Forecast: Breakup by Country (in Million US$), 2023-2028
Table 5: North America: Travel Vaccines Market: Competitive Structure
Table 6: North America: Travel Vaccines Market: Key Players
Table 1: North America: Travel Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: North America: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2023-2028
Table 3: North America: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2023-2028
Table 4: North America: Travel Vaccines Market Forecast: Breakup by Country (in Million US$), 2023-2028
Table 5: North America: Travel Vaccines Market: Competitive Structure
Table 6: North America: Travel Vaccines Market: Key Players
LIST OF FIGURES
Figure 1: North America: Travel Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Travel Vaccines Market: Value Trends (in Billion US$), 2017-2022
Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2022
Figure 6: Global: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 7: North America: Travel Vaccines Market: Value Trends (in Billion US$), 2017-2022
Figure 8: North America: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 9: North America: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 10: North America: Travel Vaccines (Mono Vaccines) Market: Value Trends (in Million US$), 2017 & 2022
Figure 11: North America: Travel Vaccines (Mono Vaccines) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 12: North America: Travel Vaccines (Combination Vaccines) Market: Value Trends (in Million US$), 2017 & 2022
Figure 13: North America: Travel Vaccines (Combination Vaccines) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 14: North America: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 15: North America: Travel Vaccines (Hepatitis A) Market: Value Trends (in Million US$), 2017 & 2022
Figure 16: North America: Travel Vaccines (Hepatitis A) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 17: North America: Travel Vaccines (DPT) Market: Value Trends (in Million US$), 2017 & 2022
Figure 18: North America: Travel Vaccines (DPT) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 19: North America: Travel Vaccines (Yellow Fever) Market: Value Trends (in Million US$), 2017 & 2022
Figure 20: North America: Travel Vaccines (Yellow Fever) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 21: North America: Travel Vaccines (Typhoid) Market: Value Trends (in Million US$), 2017 & 2022
Figure 22: North America: Travel Vaccines (Typhoid) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 23: North America: Travel Vaccines (Hepatitis B) Market: Value Trends (in Million US$), 2017 & 2022
Figure 24: North America: Travel Vaccines (Hepatitis B) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 25: North America: Travel Vaccines (Measles and Mumps) Market: Value Trends (in Million US$), 2017 & 2022
Figure 26: North America: Travel Vaccines (Measles and Mumps) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 27: North America: Travel Vaccines (Rabies) Market: Value Trends (in Million US$), 2017 & 2022
Figure 28: North America: Travel Vaccines (Rabies) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 29: North America: Travel Vaccines (Meningococcal) Market: Value Trends (in Million US$), 2017 & 2022
Figure 30: North America: Travel Vaccines (Meningococcal) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 31: North America: Travel Vaccines (Varicella) Market: Value Trends (in Million US$), 2017 & 2022
Figure 32: North America: Travel Vaccines (Varicella) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 33: North America: Travel Vaccines (Japanese Encephalitis) Market: Value Trends (in Million US$), 2017 & 2022
Figure 34: North America: Travel Vaccines (Japanese Encephalitis) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 35: North America: Travel Vaccines (Others) Market: Value Trends (in Million US$), 2017 & 2022
Figure 36: North America: Travel Vaccines (Others) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 37: North America: Travel Vaccines Market: Breakup by Country (in %), 2022
Figure 38: United States: Travel Vaccines Market: Value Trends (in Million US$), 2017-2022
Figure 39: United States: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 40: United States: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 41: United States: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 42: Canada: Travel Vaccines Market: Value Trends (in Million US$), 2017-2022
Figure 43: Canada: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 44: Canada: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 45: Canada: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 46: Mexico: Travel Vaccines Market: Value Trends (in Million US$), 2017-2022
Figure 47: Mexico: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 48: Mexico: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 49: Mexico: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 50: North America: Travel Vaccines Industry: SWOT Analysis
Figure 51: North America: Travel Vaccines Industry: Value Chain Analysis
Figure 52: North America: Travel Vaccines Industry: Porter’s Five Forces Analysis
Figure 1: North America: Travel Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Travel Vaccines Market: Value Trends (in Billion US$), 2017-2022
Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2022
Figure 6: Global: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 7: North America: Travel Vaccines Market: Value Trends (in Billion US$), 2017-2022
Figure 8: North America: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 9: North America: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 10: North America: Travel Vaccines (Mono Vaccines) Market: Value Trends (in Million US$), 2017 & 2022
Figure 11: North America: Travel Vaccines (Mono Vaccines) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 12: North America: Travel Vaccines (Combination Vaccines) Market: Value Trends (in Million US$), 2017 & 2022
Figure 13: North America: Travel Vaccines (Combination Vaccines) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 14: North America: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 15: North America: Travel Vaccines (Hepatitis A) Market: Value Trends (in Million US$), 2017 & 2022
Figure 16: North America: Travel Vaccines (Hepatitis A) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 17: North America: Travel Vaccines (DPT) Market: Value Trends (in Million US$), 2017 & 2022
Figure 18: North America: Travel Vaccines (DPT) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 19: North America: Travel Vaccines (Yellow Fever) Market: Value Trends (in Million US$), 2017 & 2022
Figure 20: North America: Travel Vaccines (Yellow Fever) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 21: North America: Travel Vaccines (Typhoid) Market: Value Trends (in Million US$), 2017 & 2022
Figure 22: North America: Travel Vaccines (Typhoid) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 23: North America: Travel Vaccines (Hepatitis B) Market: Value Trends (in Million US$), 2017 & 2022
Figure 24: North America: Travel Vaccines (Hepatitis B) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 25: North America: Travel Vaccines (Measles and Mumps) Market: Value Trends (in Million US$), 2017 & 2022
Figure 26: North America: Travel Vaccines (Measles and Mumps) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 27: North America: Travel Vaccines (Rabies) Market: Value Trends (in Million US$), 2017 & 2022
Figure 28: North America: Travel Vaccines (Rabies) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 29: North America: Travel Vaccines (Meningococcal) Market: Value Trends (in Million US$), 2017 & 2022
Figure 30: North America: Travel Vaccines (Meningococcal) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 31: North America: Travel Vaccines (Varicella) Market: Value Trends (in Million US$), 2017 & 2022
Figure 32: North America: Travel Vaccines (Varicella) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 33: North America: Travel Vaccines (Japanese Encephalitis) Market: Value Trends (in Million US$), 2017 & 2022
Figure 34: North America: Travel Vaccines (Japanese Encephalitis) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 35: North America: Travel Vaccines (Others) Market: Value Trends (in Million US$), 2017 & 2022
Figure 36: North America: Travel Vaccines (Others) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 37: North America: Travel Vaccines Market: Breakup by Country (in %), 2022
Figure 38: United States: Travel Vaccines Market: Value Trends (in Million US$), 2017-2022
Figure 39: United States: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 40: United States: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 41: United States: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 42: Canada: Travel Vaccines Market: Value Trends (in Million US$), 2017-2022
Figure 43: Canada: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 44: Canada: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 45: Canada: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 46: Mexico: Travel Vaccines Market: Value Trends (in Million US$), 2017-2022
Figure 47: Mexico: Travel Vaccines Market: Breakup by Composition (in %), 2022
Figure 48: Mexico: Travel Vaccines Market: Breakup by Disease (in %), 2022
Figure 49: Mexico: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 50: North America: Travel Vaccines Industry: SWOT Analysis
Figure 51: North America: Travel Vaccines Industry: Value Chain Analysis
Figure 52: North America: Travel Vaccines Industry: Porter’s Five Forces Analysis
